Detalhe da pesquisa
1.
Oral corticosteroid dosage and taper duration at onset in myelin oligodendrocyte glycoprotein antibody-associated disease influences time to first relapse.
J Neurol Neurosurg Psychiatry
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38744459
2.
Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60.
J Neurol Neurosurg Psychiatry
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38453478
3.
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study.
J Neurol Neurosurg Psychiatry
; 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38569872
4.
A pro-inflammatory diet in people with multiple sclerosis is associated with an increased rate of relapse and increased FLAIR lesion volume on MRI in early multiple sclerosis: A prospective cohort study.
Mult Scler
; 29(8): 1012-1023, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37148166
5.
Long-term trajectories of employment status, workhours and disability support pension status, after a first episode of CNS demyelination.
Mult Scler
; 28(11): 1793-1807, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35549477
6.
Defining secondary progressive multiple sclerosis.
Brain
; 139(Pt 9): 2395-405, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27401521
7.
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.
Ann Neurol
; 70(6): 897-912, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22190364
8.
The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosis.
Mult Scler Relat Disord
; 43: 102212, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32474286
9.
Open access publishing and the future of scientific communication.
Mult Scler Relat Disord
; 86: 105625, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38626688
10.
Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination.
Acta Neuropathol Commun
; 7(1): 145, 2019 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31481127
11.
Cancer risk and mortality in multiple sclerosis: The need for vigilance.
Mult Scler Relat Disord
; 69: 104519, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36696700
12.
Migraine and multiple sclerosis: The final answer?
Mult Scler Relat Disord
; 74: 104769, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37270888
13.
Is multiple sclerosis a glymphaticopathy?
Mult Scler Relat Disord
; 80: 105141, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38039696
14.
Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis.
JAMA Neurol
; 75(11): 1407-1415, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30083762
15.
The biological rabbit hole: Only for the blind.
Mult Scler Relat Disord
; 67: 104256, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36302291
16.
Diagnosis of multiple sclerosis: Progress or confusion?
Mult Scler Relat Disord
; 57: 103528, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35158438
17.
Onset of multiple sclerosis is preventable - time to act now!
Mult Scler Relat Disord
; 62: 103875, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35597069
18.
Favourable Outcome in a 33-Year-Old Female with Acute Haemorrhagic Leukoencephalitis.
Case Rep Neurol
; 9(1): 106-113, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28559834
19.
EBV as the "gluten of MS" hypothesis provides a rationale for trialing antiviral therapies.
Mult Scler Relat Disord
; 64: 104007, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35803161
20.
Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS.
Neurology
; 89(10): 1050-1059, 2017 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28794248